Proteonomix, Inc. (PROT)
187 Mill Lane
Mountainside
New Jersey
07092-2909
United States
Tel: 973-544-6116
Website: http://www.proteonomix.com/
70 articles about Proteonomix, Inc. (PROT)
-
Proteonomix, Inc. (PROT) Settles Litigation
4/1/2013
-
Proteonomix, Inc. (PROT) Announces Extension of Deadline
1/14/2013
-
Proteonomix, Inc. (PROT) to Require Physical Exchange of Certificates
1/11/2013
-
Proteonomix, Inc. (PROT) Updates Status of UMK-121 Testing
1/8/2013
-
Proteonomix, Inc. (PROT) Announces Restructuring
1/8/2013
-
Proteonomix, Inc. (PROT) Announces Screening of Patients With End Stage Liver Disease in Its Clinical Study of UMK-121
11/20/2012
-
Proteonomix, Inc. (PROT) Announces Finalizing ECRF for Its Clinical Trial of UMK 121 in Patients With End Stage Liver Disease
10/26/2012
-
Proteonomix, Inc. (PROT) Announces Its Clinical Trial of UMK-121 in Patients With End Stage Liver Disease Has Been Listed on ClinicalTrials.gov
10/23/2012
-
Proteonomix, Inc. (PROT) Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients With End Stage Liver Disease
10/4/2012
-
Proteonomix, Inc. (PROT) Announces Agreement With the University of Medicine and Dentistry of New Jersey to Conduct a Phase 1 Trial With UMK-121 in End-Stage Liver Disease
9/14/2012
-
Proteonomix, Inc. (PROT) Retains Numoda Corporation to Provide Clinical Trial Services for Phase 1 Trial With UMK-121 in End-Stage Liver Disease
9/12/2012
-
Proteonomix, Inc. (PROT) Engages Numoda Corporation for Clinical Trial Services
9/4/2012
-
Proteonomix, Inc. (PROT) Licenses Exclusive Worldwide Rights to Novel Anti-Tumor Technology
8/22/2012
-
Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients With End-Stage Liver Disease
8/14/2012
-
Preclinical Research with Proteonomix, Inc. (PROT)’s UMK-121 Featured in Oral Presentation at the International Society for Cellular Therapy 18th Annual Meeting
6/7/2012
-
Proteonomix, Inc. (PROT) Announces Termination of Contract with the University of Miami
4/11/2012
-
Proteonomix, Inc. (PROT) Updates Progress on Multiple Programs
4/9/2012
-
Proteonomix, Inc. (PROT) Updates Progress of Proteoderm, Inc. Subsidiary
3/29/2012
-
Proteonomix, Inc. (PROT) Completes $3.8 Million Private Placement
3/19/2012
-
Proteonomix, Inc. (PROT) Announces a Private Placement of $3.8 Million
3/6/2012